Cargando…
Novel Acylguanidine Derivatives Targeting Smoothened Induce Antiproliferative and Pro-Apoptotic Effects in Chronic Myeloid Leukemia Cells
The most relevant therapeutic approaches to treat CML rely on the administration of tyrosine kinase inhibitors (TKIs) like Imatinib, which are able to counteract the activity of Bcr-Abl protein increasing patient’s life expectancy and survival. Unfortunately, there are some issues TKIs are not able...
Autores principales: | Chiarenza, Alessandra, Manetti, Fabrizio, Petricci, Elena, Ruat, Martial, Naldini, Antonella, Taddei, Maurizio, Carraro, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774938/ https://www.ncbi.nlm.nih.gov/pubmed/26934052 http://dx.doi.org/10.1371/journal.pone.0149919 |
Ejemplares similares
-
Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened Inhibitors
por: Pietrobono, Silvia, et al.
Publicado: (2018) -
Targeted inhibition of Hedgehog-GLI signaling by novel acylguanidine derivatives inhibits melanoma cell growth by inducing replication stress and mitotic catastrophe
por: Pietrobono, Silvia, et al.
Publicado: (2018) -
Viral targets of acylguanidines
por: Gazina, Elena V., et al.
Publicado: (2012) -
Smoothened/AMP-Activated Protein Kinase Signaling in Oligodendroglial Cell Maturation
por: Del Giovane, Alice, et al.
Publicado: (2022) -
Hedgehog associated to microparticles inhibits adipocyte differentiation via a non-canonical pathway
por: Fleury, Audrey, et al.
Publicado: (2016)